DEBRAH VAMBE to Antitubercular Agents
This is a "connection" page, showing publications DEBRAH VAMBE has written about Antitubercular Agents.
Connection Strength
1.211
-
Understanding the role of video direct observed therapy for patients on an oral short-course regimen for multi-drug resistant tuberculosis: findings from a qualitative study in Eswatini. BMC Infect Dis. 2024 Aug 15; 24(1):829.
Score: 0.192
-
The introduction of video-enabled directly observed therapy (video-DOT) for patients with drug-resistant TB disease in Eswatini amid the COVID-19 pandemic - a retrospective cohort study. BMC Health Serv Res. 2024 Jun 03; 24(1):699.
Score: 0.189
-
Drug-resistant tuberculosis: a persistent global health concern. Nat Rev Microbiol. 2024 Oct; 22(10):617-635.
Score: 0.186
-
Bedaquiline and delamanid result in low rates of unfavourable outcomes among TB patients in Eswatini. Int J Tuberc Lung Dis. 2020 10 01; 24(10):1095-1102.
Score: 0.147
-
Successful expansion of community-based drug-resistant TB care in rural Eswatini - a retrospective cohort study. Trop Med Int Health. 2019 10; 24(10):1243-1258.
Score: 0.136
-
Model of care and risk factors for poor outcomes in patients on multi-drug resistant tuberculosis treatment at two facilities in eSwatini (formerly Swaziland), 2011-2013. PLoS One. 2018; 13(10):e0205601.
Score: 0.128
-
Six-Month Response to Delamanid Treatment in MDR TB Patients. Emerg Infect Dis. 2017 10; 23(10).
Score: 0.119
-
Rapid molecular diagnostics of tuberculosis resistance by targeted stool sequencing. Genome Med. 2022 05 19; 14(1):52.
Score: 0.041
-
Clinical perspectives on treatment of rifampicin-resistant/multidrug-resistant TB. Int J Tuberc Lung Dis. 2020 11 01; 24(11):1134-1144.
Score: 0.037
-
'She is like my mother': Community-based care of drug-resistant tuberculosis in rural Eswatini. Glob Public Health. 2021 06; 16(6):911-923.
Score: 0.036